Today, in addition to treating diabetes and obesity, these medications are showing promise in the treatment of countless other health problems, including sleep apnea, kidney disease, inflammation and heart disease
Usually not for seniors with absorption issues
2739 Dipeptidyl peptidase 4 (DDP4) is an enzyme responsible for glucagon like peptide-1 inactivation and plays an important role in glucose metabolism
Fibre content is worth considering, especially as constipation is a common side effect of GLP-1 medications
I believe the key lies in starting with very low doses and gradually increasing as tolerated, always in conjunction with comprehensive mast cell support including dietary modifications, stress management, and targeted supplementation
Throughout, pharma teams should heed the fundamental lesson here: availability of a life-changing therapy is no guarantee of patient access, unless the complex machinery of insurance coverage is navigated successfully